Position in AMGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$3,437,967
+$115,096 QoQ
Shares Held
9,494
+0.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.48%
of 13F equity value
Holder Rank
#1,002
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aull & Monroe Investment Management Corp holds $30,785,948 across 9 Drug Manufacturers - General names. AMGN ranks #4 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,329 | $11,189,483 | |
| 2 | JNJ |
Johnson & Johnson
|
30,562 | $7,761,831 | |
| 3 | ABBV |
AbbVie Inc.
|
14,519 | $3,653,561 | |
| 4 | AMGN |
Amgen Inc
This page
|
9,494 | $3,437,967 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,386 | $2,362,601 | |
| 6 | PFE |
Pfizer Inc
|
38,318 | $922,697 | |
| 7 | NVS |
Novartis AG
|
3,771 | $590,991 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
9,214 | $530,910 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,437,967 | 9,494 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $3,322,871 | 9,444 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $3,091,115 | 9,444 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $2,665,379 | 9,445 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,592,185 | 9,284 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $3,244,481 | 10,414 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,740,368 | 10,514 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,545,598 | 11,004 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $3,535,371 | 11,315 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $3,408,996 | 11,990 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $3,582,968 | 12,440 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $3,403,576 | 12,664 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,844,964 | 12,814 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $3,097,784 | 12,814 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,417,996 | 13,014 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,043,801 | 13,504 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,285,523 | 13,504 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $3,292,137 | 13,614 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $3,017,747 | 13,414 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $2,905,649 | 13,664 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $3,343,275 | 13,716 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $3,412,677 | 13,716 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $3,219,109 | 14,001 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $3,483,262 | 13,705 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $3,232,461 | 13,705 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $2,920,325 | 14,405 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||